Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

72 results

Filters applied: . Clear all
Page 1
Direct oral anticoagulants versus vitamin K antagonists in the first 3 months after bioprosthetic valve replacement: a systematic review and meta-analysis.
Eikelboom R, Whitlock RP, Muzaffar R, Lopes RD, Siegal D, Schulman S, Belley-Côté EP. Eikelboom R, et al. Among authors: schulman s. Eur J Cardiothorac Surg. 2023 Apr 3;63(4):ezad110. doi: 10.1093/ejcts/ezad110. Eur J Cardiothorac Surg. 2023. PMID: 36971601
Future studies should focus on surgical valves and should include long-term follow-up to assess any potential impact of randomized therapy on valve durability....
Future studies should focus on surgical valves and should include long-term follow-up to assess any potential impact of randomized th …
The risk of major bleeding in patients with factor V Leiden or prothrombin G20210A gene mutation while on extended anticoagulant treatment for venous thromboembolism.
Caiano L, Kovacs MJ, Lazo-Langner A, Anderson DR, Kahn SR, Shah V, Kaatz S, Zide RS, Schulman S, Chagnon I, Mallick R, Rodger MA, Wells PS. Caiano L, et al. Among authors: schulman s. J Thromb Haemost. 2023 Mar;21(3):553-558. doi: 10.1016/j.jtha.2022.12.021. Epub 2022 Dec 30. J Thromb Haemost. 2023. PMID: 36710196 Free article.
METHODS: This multicentre, multinational, prospective cohort study evaluated adults receiving long-term anticoagulants after a VTE event. We analyzed the incidence of major bleeding as the primary outcome, according to the genotype for FVL and PGM (wild-type and heterozygo …
METHODS: This multicentre, multinational, prospective cohort study evaluated adults receiving long-term anticoagulants after a VTE ev …
Instituting a Curriculum for Cardio-Obstetrics Subspecialty Fellowship Training.
Minhas AS, Goldstein SA, Vaught AJ, Lewey J, Ward C, Schulman SP, Michos ED. Minhas AS, et al. Among authors: schulman sp. Methodist Debakey Cardiovasc J. 2022 Jun 3;18(3):14-23. doi: 10.14797/mdcvj.1101. eCollection 2022. Methodist Debakey Cardiovasc J. 2022. PMID: 35734150 Free PMC article. Review.
Adverse pregnancy outcomes such as preeclampsia and gestational diabetes heighten the risk of cardiovascular complications during pregnancy and the peripartum period and are associated with long-term cardiovascular risks. The field of cardio-obstetrics is a subspecialty wi …
Adverse pregnancy outcomes such as preeclampsia and gestational diabetes heighten the risk of cardiovascular complications during pregnancy …
Long-Term Risk of Major Bleeding after Discontinuing Anticoagulation for Unprovoked Venous Thromboembolism: A Systematic Review and Meta-analysis.
Khan F, Rahman A, Tritschler T, Carrier M, Kearon C, Weitz JI, Schulman S, Couturaud F, Becattini C, Agnelli G, Brighton TA, Lensing AWA, Pinede L, Parpia S, Geersing GJ, Takada T, Bradbury CA, Andreozzi GM, Palareti G, Prandoni P, Buller HR, Mallick R, Hutton B, Thavorn K, Le Gal G, Rodger MA, Fergusson DA. Khan F, et al. Among authors: schulman s. Thromb Haemost. 2022 Jul;122(7):1186-1197. doi: 10.1055/a-1690-8728. Epub 2021 Nov 9. Thromb Haemost. 2022. PMID: 34753191
BACKGROUND: The long-term risk of major bleeding after discontinuing anticoagulant therapy for a first unprovoked venous thromboembolism (VTE) is uncertain. ...
BACKGROUND: The long-term risk of major bleeding after discontinuing anticoagulant therapy for a first unprovoked venous thromboembol …
Post-thrombotic syndrome in patients with venous thromboembolism treated with dabigatran or warfarin: A long-term cross-sectional follow-up of RE-COVER study patients.
Wik HS, Kahn SR, Eriksson H, Morrison D, Ghanima W, Schulman S, Sandset PM. Wik HS, et al. Among authors: schulman s. J Thromb Haemost. 2021 Oct;19(10):2495-2503. doi: 10.1111/jth.15449. Epub 2021 Jul 28. J Thromb Haemost. 2021. PMID: 34255420 Free article. Clinical Trial.
BACKGROUND: Studies suggest that the direct factor Xa inhibitor rivaroxaban compared to warfarin reduces the risk of post-thrombotic syndrome (PTS) after deep vein thrombosis (DVT), but this has not been evaluated for oral direct thrombin inhibitors. OBJECTIVES: To compare the lo …
BACKGROUND: Studies suggest that the direct factor Xa inhibitor rivaroxaban compared to warfarin reduces the risk of post-thrombotic syndrom …
In-Hospital Management and Outcomes of Patients With Acute Myocardial Infarction and Influenza.
Cardoso R, Rivera M, Czarny MJ, Knijnik L, Fernandes A, Blumenthal RS, Hasan RK, Schulman SP. Cardoso R, et al. Among authors: schulman sp. Am J Cardiol. 2020 Mar 15;125(6):840-844. doi: 10.1016/j.amjcard.2019.12.032. Epub 2019 Dec 27. Am J Cardiol. 2020. PMID: 31932083
Patients with influenza infection are at increased risk of acute myocardial infarction (AMI). There are limited data on the short-term prognosis and management of patients with AMI and concomitant influenza. ...
Patients with influenza infection are at increased risk of acute myocardial infarction (AMI). There are limited data on the short-term …
Perioperative Management of Patients With Atrial Fibrillation Receiving a Direct Oral Anticoagulant.
Douketis JD, Spyropoulos AC, Duncan J, Carrier M, Le Gal G, Tafur AJ, Vanassche T, Verhamme P, Shivakumar S, Gross PL, Lee AYY, Yeo E, Solymoss S, Kassis J, Le Templier G, Kowalski S, Blostein M, Shah V, MacKay E, Wu C, Clark NP, Bates SM, Spencer FA, Arnaoutoglou E, Coppens M, Arnold DM, Caprini JA, Li N, Moffat KA, Syed S, Schulman S. Douketis JD, et al. Among authors: schulman s. JAMA Intern Med. 2019 Nov 1;179(11):1469-1478. doi: 10.1001/jamainternmed.2019.2431. JAMA Intern Med. 2019. PMID: 31380891 Free PMC article.
Participants (n = 3007) had AF; were 18 years of age or older; were long-term users of apixaban, dabigatran etexilate, or rivaroxaban; were scheduled for an elective surgery or procedure; and could adhere to the DOAC therapy interruption protocol. ...
Participants (n = 3007) had AF; were 18 years of age or older; were long-term users of apixaban, dabigatran etexilate, or rivaroxaban …
Long term risk of symptomatic recurrent venous thromboembolism after discontinuation of anticoagulant treatment for first unprovoked venous thromboembolism event: systematic review and meta-analysis.
Khan F, Rahman A, Carrier M, Kearon C, Weitz JI, Schulman S, Couturaud F, Eichinger S, Kyrle PA, Becattini C, Agnelli G, Brighton TA, Lensing AWA, Prins MH, Sabri E, Hutton B, Pinede L, Cushman M, Palareti G, Wells GA, Prandoni P, Büller HR, Rodger MA; MARVELOUS Collaborators. Khan F, et al. Among authors: schulman s. BMJ. 2019 Jul 24;366:l4363. doi: 10.1136/bmj.l4363. BMJ. 2019. PMID: 31340984 Free PMC article.
These estimates should inform clinical practice guidelines, enhance confidence in counselling patients of their prognosis, and help guide decision making about long term management of unprovoked VTE. SYSTEMATIC REVIEW REGISTRATION: PROSPERO CRD42017056309....
These estimates should inform clinical practice guidelines, enhance confidence in counselling patients of their prognosis, and help guide de …
Long-term risk of recurrence in patients with a first unprovoked venous thromboembolism managed according to d-dimer results; A cohort study.
Kearon C, Parpia S, Spencer FA, Schulman S, Stevens SM, Shah V, Bauer KA, Douketis JD, Lentz SR, Kessler CM, Connors JM, Ginsberg JS, Spadafora L, Julian JA. Kearon C, et al. Among authors: schulman s. J Thromb Haemost. 2019 Jul;17(7):1144-1152. doi: 10.1111/jth.14458. Epub 2019 May 20. J Thromb Haemost. 2019. PMID: 31033194 Free article.
Essentials Long-term recurrence risk after a first unprovoked VTE with negative d-dimer levels is uncertain. ...Negative d-dimers do not justify stopping anticoagulants in most men but appear to in most women. BACKGROUND: The long-term risk of recurrence in patients …
Essentials Long-term recurrence risk after a first unprovoked VTE with negative d-dimer levels is uncertain. ...Negative d-dimers do …
Fatal recurrent VTE after anticoagulant treatment for unprovoked VTE: a systematic review.
van der Wall SJ, van der Pol LM, Ende-Verhaar YM, Cannegieter SC, Schulman S, Prandoni P, Rodger M, Huisman MV, Klok FA. van der Wall SJ, et al. Among authors: schulman s. Eur Respir Rev. 2018 Nov 28;27(150):180094. doi: 10.1183/16000617.0094-2018. Print 2018 Dec 31. Eur Respir Rev. 2018. PMID: 30487292 Free PMC article.
Current guidelines recommend long-term anticoagulant therapy in patients with unprovoked venous thromboembolism (VTE). ...These numbers are a solid benchmark for comparison to the risks associated with long-term anticoagulation treatment for the decision on the opti …
Current guidelines recommend long-term anticoagulant therapy in patients with unprovoked venous thromboembolism (VTE). ...These numbe …
72 results